EDITORIAL
Published on 02 Feb 2022
Editorial: Repurposed Drugs as Immune-Modulators to Combat Infectious Diseases
doi 10.3389/fimmu.2022.848373
- 1,449 views
- 1 citation
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Repurposed Drugs as Immune- Modulators to Combat Infectious Diseases
Repurposed Drugs as Immune- Modulators to Combat Infectious Diseases
25k
Total Downloads
88k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 20 Oct 2021
Evaluation of Berberine as an Adjunct to TB Treatment
doi 10.3389/fimmu.2021.656419
- 4,061 views
- 12 citations
REVIEW
Published on 24 Jun 2021
Something Old, Something New: Ion Channel Blockers as Potential Anti-Tuberculosis Agents
doi 10.3389/fimmu.2021.665785
- 4,886 views
- 10 citations
ORIGINAL RESEARCH
Published on 27 May 2021
Co-Administration of Anticancer Candidate MK-2206 Enhances the Efficacy of BCG Vaccine Against Mycobacterium tuberculosis in Mice and Guinea Pigs
doi 10.3389/fimmu.2021.645962
- 3,563 views
- 1 citation
ORIGINAL RESEARCH
Published on 04 May 2021
Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome
doi 10.3389/fimmu.2021.663295
- 5,169 views
- 44 citations
ORIGINAL RESEARCH
Published on 28 Apr 2021
Longer-Term Omega-3 LCPUFA More Effective Adjunct Therapy for Tuberculosis Than Ibuprofen in a C3HeB/FeJ Tuberculosis Mouse Model
doi 10.3389/fimmu.2021.659943
- 3,445 views
- 6 citations
MINI REVIEW
Published on 19 Apr 2021
Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
doi 10.3389/fimmu.2021.660916
- 5,536 views
- 54 citations
REVIEW
Published on 13 Apr 2021
Repurposing Immunomodulatory Drugs to Combat Tuberculosis
doi 10.3389/fimmu.2021.645485
- 8,313 views
- 37 citations
ORIGINAL RESEARCH
Published on 26 Mar 2021
Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
doi 10.3389/fimmu.2021.647728
- 4,753 views
- 20 citations
MINI REVIEW
Published on 12 Mar 2021
The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis
doi 10.3389/fimmu.2021.623941
- 2,593 views
- 6 citations
REVIEW
Published on 22 Jan 2021
The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex
doi 10.3389/fimmu.2020.623119
- 14,858 views
- 23 citations
CASE REPORT
Published on 25 Aug 2020
Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome
doi 10.3389/fimmu.2020.01942
- 2,944 views
- 18 citations
Published in
Frontiers in Immunology
- Vaccines and Molecular Therapeutics
Participating Journals
Frontiers in Public Health
Vaccines and Molecular TherapeuticsOffline
- 3.0 impact factor
- 4.8 citescore
Impact
- 88kTopic views
- 60kArticle views
- 25kArticle downloads